Anticancer Molecular Mechanisms of Resveratrol

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2016 May 6

PMID 27148534

Citations 139

Authors

Elena M Varoni

Alfredo Fabrizio Lo Faro

Javad Sharifi-Rad

Marcello Iriti

Affiliations

Soon will be listed here.

Abstract

Resveratrol is a pleiotropic phytochemical belonging to the stilbene family. Though it is only significantly present in grape products, a huge amount of preclinical studies investigated its anticancer properties in a plethora of cellular and animal models. Molecular mechanisms of resveratrol involved signaling pathways related to extracellular growth factors and receptor tyrosine kinases; formation of multiprotein complexes and cell metabolism; cell proliferation and genome instability; cytoplasmic tyrosine kinase signaling (cytokine, integrin, and developmental pathways); signal transduction by the transforming growth factor-β super-family; apoptosis and inflammation; and immune surveillance and hormone signaling. Resveratrol also showed a promising role to counteract multidrug resistance: in adjuvant therapy, associated with 5-fluoruracyl and cisplatin, resveratrol had additive and/or synergistic effects increasing the chemosensitization of cancer cells. Resveratrol, by acting on diverse mechanisms simultaneously, has been emphasized as a promising, multi-target, anticancer agent, relevant in both cancer prevention and treatment.

Citing Articles

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma.

Ding Y, Chen Q Front Oncol. 2025; 14:1456959.

PMID: 40028002 PMC: 11867957. DOI: 10.3389/fonc.2024.1456959.

Resveratrol-Loaded Pluronic Micelles Ameliorate Scopolamine-Induced Cognitive Dysfunction Targeting Acetylcholinesterase Activity and Programmed Cell Death.

Lazarova M, Stefanova M, Tsvetanova E, Georgieva A, Tasheva K, Radeva L Int J Mol Sci. 2024; 25(23).

PMID: 39684486 PMC: 11641279. DOI: 10.3390/ijms252312777.

Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma.

Polpichai N, Saowapa S, Danpanichkul P, Chan S, Sierra L, Blagoie J J Clin Med. 2024; 13(22).

PMID: 39597914 PMC: 11594971. DOI: 10.3390/jcm13226770.

Resveratrol's bibliometric and visual analysis from 2014 to 2023.

Wei H, Fang G, Song W, Cao H, Dong R, Huang Y Front Plant Sci. 2024; 15:1423323.

PMID: 39439517 PMC: 11493714. DOI: 10.3389/fpls.2024.1423323.

Potential of Resveratrol to Combine with Hydrogel for Photodynamic Therapy against Bacteria and Cancer-A Review.

Law S, Liu C, Tong C, Au D Biomedicines. 2024; 12(9).

PMID: 39335608 PMC: 11428695. DOI: 10.3390/biomedicines12092095.

References

Cosco D, Paolino D, Maiuolo J, Di Marzio L, Carafa M, Ventura C . Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery. Int J Pharm. 2015; 489(1-2):1-10. DOI: 10.1016/j.ijpharm.2015.04.056. View

Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C . Resveratrol and breast cancer risk. Eur J Cancer Prev. 2005; 14(2):139-42. DOI: 10.1097/00008469-200504000-00009. View

Britton R, Kovoor C, Brown K . Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms. Ann N Y Acad Sci. 2015; 1348(1):124-33. DOI: 10.1111/nyas.12796. View

Wong J, Fiscus R . Resveratrol at anti-angiogenesis/anticancer concentrations suppresses protein kinase G signaling and decreases IAPs expression in HUVECs. Anticancer Res. 2015; 35(1):273-81. View

Yu X, Jaskula-Sztul R, Ahmed K, Harrison A, Kunnimalaiyaan M, Chen H . Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol Cancer Ther. 2013; 12(7):1276-87. PMC: 3707971. DOI: 10.1158/1535-7163.MCT-12-0841. View

Kucinska M, Piotrowska H, Luczak M, Mikula-Pietrasik J, Ksiazek K, Wozniak M . Effects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogs. Chem Biol Interact. 2014; 209:96-110. DOI: 10.1016/j.cbi.2013.12.009. View

Basso E, Fiore M, Leone S, Degrassi F, Cozzi R . Effects of resveratrol on topoisomerase II-α activity: induction of micronuclei and inhibition of chromosome segregation in CHO-K1 cells. Mutagenesis. 2013; 28(3):243-8. DOI: 10.1093/mutage/ges067. View

Leone S, Basso E, Polticelli F, Cozzi R . Resveratrol acts as a topoisomerase II poison in human glioma cells. Int J Cancer. 2011; 131(3):E173-8. DOI: 10.1002/ijc.27358. View

Kubota T, Uemura Y, Kobayashi M, Taguchi H . Combined effects of resveratrol and paclitaxel on lung cancer cells. Anticancer Res. 2003; 23(5A):4039-46. View

10.

Inoue H, Nakata R . Resveratrol Targets in Inflammation. Endocr Metab Immune Disord Drug Targets. 2015; 15(3):186-95. DOI: 10.2174/1871530315666150316120316. View

11.

Ahmad N, Adhami V, Afaq F, Feyes D, Mukhtar H . Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res. 2001; 7(5):1466-73. View

12.

Latruffe N, Lancon A, Frazzi R, Aires V, Delmas D, Michaille J . Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation. Ann N Y Acad Sci. 2015; 1348(1):97-106. DOI: 10.1111/nyas.12819. View

13.

Schroeter A, Groh I, Del Favero G, Pignitter M, Schueller K, Somoza V . Inhibition of topoisomerase II by phase II metabolites of resveratrol in human colon cancer cells. Mol Nutr Food Res. 2015; 59(12):2448-59. DOI: 10.1002/mnfr.201500352. View

14.

Adhami V, Afaq F, Ahmad N . Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun. 2001; 288(3):579-85. DOI: 10.1006/bbrc.2001.5819. View

15.

Gu S, Chen C, Jiang X, Zhang Z . Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells. Biol Trace Elem Res. 2014; 163(1-2):112-23. DOI: 10.1007/s12011-014-0186-2. View

16.

Chin Y, Yang S, Chang T, Changou C, Lai H, Fu E . Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERα status. Oncotarget. 2015; 6(34):35866-79. PMC: 4742147. DOI: 10.18632/oncotarget.5482. View

17.

Buhrmann C, Shayan P, Kraehe P, Popper B, Goel A, Shakibaei M . Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer. Biochem Pharmacol. 2015; 98(1):51-68. DOI: 10.1016/j.bcp.2015.08.105. View

18.

Ren Z, Wang L, Cui J, Huoc Z, Xue J, Cui H . Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities. Pharmazie. 2013; 68(8):689-94. View

19.

Ruotolo R, Calani L, Fietta E, Brighenti F, Crozier A, Meda C . Anti-estrogenic activity of a human resveratrol metabolite. Nutr Metab Cardiovasc Dis. 2013; 23(11):1086-92. DOI: 10.1016/j.numecd.2013.01.002. View

20.

Bickenbach K, Veerapong J, Shao M, Mauceri H, Posner M, Kron S . Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. Cancer Gene Ther. 2007; 15(3):133-9. DOI: 10.1038/sj.cgt.7701103. View